Showing 1 - 10 of 252
In this article we analyse how the costs of treating patients with HIV infection in the US have changed over time, with an emphasis on the relationship between inpatient hospitalization costs and the costs of highly active antiretroviral therapy (HAART). We examine how HIV treatment modes have...
Persistent link: https://www.econbiz.de/10008489679
Persistent link: https://www.econbiz.de/10009647779
Although male circumcision (MC) has been a widespread practice in some regions, while relatively new in others, it has recently ascended in popularity as a HIV-reduction intervention, particularly in areas with high rates of HIV but low rates of MC. However, the uptake and potential...
Persistent link: https://www.econbiz.de/10009647780
The PleurX peritoneal drainage catheter for drainage of malignant ascites in a community setting has been evaluated by the NICE Medical Technologies Evaluation Programme. This article outlines the evidence included in the Sponsor's submission, the independent critique by the External Assessment...
Persistent link: https://www.econbiz.de/10011005059
This paper examines the service-wide costs to the English NHS that are associated with a Hospital Trust expanding the utilisation of cell salvage techniques as an alternative to using donated blood collected from volunteer donors. Costs in the respective NHS organisations should not be viewed in...
Persistent link: https://www.econbiz.de/10005243065
Background: In order to increase price competition, government regulations focus on controlling drug costs. Drug costs after patent expiry are an area of particular interest because the substitution of branded medication with generics represents an opportunity for lowering drug costs. However,...
Persistent link: https://www.econbiz.de/10005243067
Background: It has long been recognized that brand name prescription medications are more expensive in the US than in Canada. However, non-peer-reviewed reports contend that this is not the case for generic medications. Objective: To compare prices for generic prescription medications in the US...
Persistent link: https://www.econbiz.de/10005243071
Background:Background: One of the challenges when undertaking economic evaluations of weight management interventions is to adequately assess future health impacts. Clinical trials commonly measure impacts using surrogate outcomes, such as reductions in body mass index, and investigators need to...
Persistent link: https://www.econbiz.de/10010541441
Background:Background: Osteoporosis is a common condition and the economic burden of osteoporosis-related fractures is significant. While studies have reported the incremental or attributable costs of osteoporosis-related fracture, data on the economic impact of osteoporosis-related fractures in...
Persistent link: https://www.econbiz.de/10010541442
Background: All age groups are affected by influenza infection, resulting in significant medical and economic burden. Influenza infection of healthy working adults can have a marked effect on companies due to lost work days and reduced productivity. Studies in corporate settings have shown that...
Persistent link: https://www.econbiz.de/10010614270